Bacteraemia Secondary to Tooth Extraction: Chlorhexidine Prophylaxis Protocols
Launched by UNIVERSITY OF SANTIAGO DE COMPOSTELA · May 25, 2014
Trial Information
Current as of June 01, 2025
Completed
Keywords
ClinConnect Summary
The study group will be formed of patients undergoing tooth extraction under local anaesthesia in the Department of Stomatology and Maxillofacial Surgery of the Santo Antonio General Hospital (Oporto, Portugal).The following exclusion criteria will be applied: patients under 18 years of age; antibiotic treatment in the previous three months; routine use of oral antiseptics; and any type of congenital or acquired immunodeficiency or other disease that can favour the onset of infection or haemorrhagic complications. Applying these criteria and after a statistic power test, the sample will be ...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • with need for dental extraction
- Exclusion Criteria:
- • patients under 18 years of age
- • antibiotic treatment in the previous three months
- • routine use of oral antiseptics
- • any type of congenital or acquired immunodeficiency or other disease that could favour the onset of infection or haemorrhagic complications
About University Of Santiago De Compostela
The University of Santiago de Compostela, a prestigious institution located in Spain, is dedicated to advancing scientific research and healthcare through innovative clinical trials. With a rich history of academic excellence, the university fosters a multidisciplinary approach, bringing together experts in medicine, pharmacology, and public health to conduct rigorous studies aimed at improving patient outcomes. Committed to ethical practices and the highest standards of research integrity, the university collaborates with various stakeholders, including healthcare providers and industry partners, to translate findings into real-world applications that enhance medical knowledge and treatment options.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Oporto, , Portugal
Santiago De Compostela, Galicia/A Coruña, Spain
Patients applied
Trial Officials
Inmaculada Tomas
Principal Investigator
Senior lecturer at University of Santiago de Compostela
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials